Drug intelligence / Profile preview

siInhba

Development stage
Preclinical
Lead developer
Seoul National University
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intralesional, Intratumoral, Parenteral
01

Overview

siInhba is a small interfering RNA (siRNA) designed to target and silence the expression of the Inhba gene, which encodes the inhibin beta A subunit (a component of activin A). Activin A is a member of the transforming growth factor-beta (TGF-beta) superfamily and a well-documented inducer of muscle atrophy. In preclinical models of periodontitis, local administration of siInhba into periodontitis-affected gingiva has been shown to significantly reduce serum activin A levels, thereby preventing systemic skeletal muscle atrophy and restoring muscle mass and myofiber size without causing apparent systemic adverse effects. Additionally, siInhba has been investigated in preclinical models of pancreatic ductal adenocarcinoma to prevent cancer-associated muscle wasting.

Other names
Inhba siRNAInhba small interfering RNAactivin A siRNAinhibin beta A siRNAsi-INHBA
02

Targets

Activin A

Beyond the preview

Go deeper on siInhba.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on siInhba.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call